Texas Oncology - Denton South — Denton, Texas

Texas Oncology - Denton South is a clinical research site located in Denton, Texas, United States 76210.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology - Denton South has participated in 11 clinical trials with 1 currently active.

Therapeutic areas: Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, GIST, HER2 Positive Breast Cancer.

Sponsors: Oncolytics Biotech, Blueprint Medicines Corporation, Seagen Inc..

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Denton South?

Texas Oncology - Denton South has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Denton South conducted?

Texas Oncology - Denton South has 11 clinical trials on record, with 1 currently active. Their work covers Metastatic or Recurrent Squamous Cell Carcinoma of the Lung, GIST, HER2 Positive Breast Cancer.

Is Texas Oncology - Denton South accredited by Crixeo Health?

Yes — Texas Oncology - Denton South holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology - Denton South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.